Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients.
Journal
The Journal of bone and joint surgery. American volume
ISSN: 1535-1386
Titre abrégé: J Bone Joint Surg Am
Pays: United States
ID NLM: 0014030
Informations de publication
Date de publication:
06 05 2020
06 05 2020
Historique:
entrez:
8
5
2020
pubmed:
8
5
2020
medline:
21
5
2020
Statut:
ppublish
Résumé
Studies of the novel coronavirus-induced disease COVID-19 in Wuhan, China, have elucidated the epidemiological and clinical characteristics of this disease in the general population. The present investigation summarizes the clinical characteristics and early prognosis of COVID-19 infection in a cohort of patients with fractures. Data on 10 patients with a fracture and COVID-19 were collected from 8 different hospitals located in the Hubei province from January 1, 2020, to February 27, 2020. Analyses of early prognosis were based on clinical outcomes and trends in laboratory results during treatment. All 10 patients presented with limited activity related to the fracture. The most common signs were fever, cough, and fatigue at the time of presentation (7 patients each). Other, less common signs included sore throat (4 patients), dyspnea (5 patients), chest pain (1 patient), nasal congestion (1 patient), headache (1 patient), dizziness (3 patients), abdominal pain (1 patient), and vomiting (1 patient). Lymphopenia (<1.0 × 10 cells/L) was identified in 6 of 10 patients, 9 of 9 patients had a high serum level of D-dimer, and 9 of 9 patients had a high level of C-reactive protein. Three patients underwent surgery, whereas the others were managed nonoperatively because of their compromised status. Four patients died on day 8 (3 patients) or day 14 (1 patient) after admission. The clinical outcomes for the surviving patients are not yet determined. The clinical characteristics and early prognosis of COVID-19 in patients with fracture tended to be more severe than those reported for adult patients with COVID-19 without fracture. This finding may be related to the duration between the development of symptoms and presentation. Surgical treatment should be carried out cautiously or nonoperative care should be chosen for patients with fracture in COVID-19-affected areas, especially older individuals with intertrochanteric fractures. Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Sections du résumé
BACKGROUND
Studies of the novel coronavirus-induced disease COVID-19 in Wuhan, China, have elucidated the epidemiological and clinical characteristics of this disease in the general population. The present investigation summarizes the clinical characteristics and early prognosis of COVID-19 infection in a cohort of patients with fractures.
METHODS
Data on 10 patients with a fracture and COVID-19 were collected from 8 different hospitals located in the Hubei province from January 1, 2020, to February 27, 2020. Analyses of early prognosis were based on clinical outcomes and trends in laboratory results during treatment.
RESULTS
All 10 patients presented with limited activity related to the fracture. The most common signs were fever, cough, and fatigue at the time of presentation (7 patients each). Other, less common signs included sore throat (4 patients), dyspnea (5 patients), chest pain (1 patient), nasal congestion (1 patient), headache (1 patient), dizziness (3 patients), abdominal pain (1 patient), and vomiting (1 patient). Lymphopenia (<1.0 × 10 cells/L) was identified in 6 of 10 patients, 9 of 9 patients had a high serum level of D-dimer, and 9 of 9 patients had a high level of C-reactive protein. Three patients underwent surgery, whereas the others were managed nonoperatively because of their compromised status. Four patients died on day 8 (3 patients) or day 14 (1 patient) after admission. The clinical outcomes for the surviving patients are not yet determined.
CONCLUSIONS
The clinical characteristics and early prognosis of COVID-19 in patients with fracture tended to be more severe than those reported for adult patients with COVID-19 without fracture. This finding may be related to the duration between the development of symptoms and presentation. Surgical treatment should be carried out cautiously or nonoperative care should be chosen for patients with fracture in COVID-19-affected areas, especially older individuals with intertrochanteric fractures.
LEVEL OF EVIDENCE
Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Identifiants
pubmed: 32379114
doi: 10.2106/JBJS.20.00390
pii: 00004623-202005060-00004
pmc: PMC7219849
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
750-758Commentaires et corrections
Type : CommentIn
Références
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Lancet. 2020 Feb 29;395(10225):698-708
pubmed: 32050090
J Bone Joint Surg Am. 2003 Jul;85(7):1339-42
pubmed: 12851360
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Exp Ther Med. 2019 Jul;18(1):531-536
pubmed: 31258690
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA. 1983 Jun 24;249(24):3342-6
pubmed: 6854870
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Eur J Clin Nutr. 2017 Nov;71(11):1273-1277
pubmed: 29019343
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
JAMA. 2020 Feb 7;:
pubmed: 32031570
JAMA Intern Med. 2018 Jan 1;178(1):75-83
pubmed: 29204597
PLoS One. 2017 Aug 9;12(8):e0182614
pubmed: 28793342
JAMA Surg. 2017 Jul 19;152(7):e171032
pubmed: 28492816
Osteoporos Int. 2016 Oct;27(10):3001-9
pubmed: 27241669
Lancet. 2020 Feb 29;395(10225):661-662
pubmed: 32050089
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551